Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000152407 | SCV000201426 | likely benign | not specified | 2014-05-01 | criteria provided, single submitter | clinical testing | 11203+9C>T in intron 47 of TTN: This variant is not expected to have clinical si gnificance because it is not located within the splice consensus sequence. |
Gene |
RCV000152407 | SCV000236733 | benign | not specified | 2014-12-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000460720 | SCV000555469 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-08 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000152407 | SCV001158190 | benign | not specified | 2019-03-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840100 | SCV002100734 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840101 | SCV002100735 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840102 | SCV002100736 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001840099 | SCV002100737 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing |